SOM Biotech aims to strengthen its communication and investor relations strategy with the support of Maqua Capital

posted on July 24, 2019

As an essential part of SOM  Biotech´s strategy to strengthen its visibility within the investment community and with all its stakeholders, the company has hired the services of Maqua Capital, a consulting firm specialized in Investor Relations and Financial Communication. Maqua Capital will design and implement a strategic corporate communication and investor relations plan to ensure the consistency and effectiveness of SOM Biotech´s communication with all its stakeholders. Maqua Capital will work closely with SOM Biotech to develop a thorough understanding of SOM Biotech´s business and its unique value proposition. With this insight, SOM Biotech strives to effective communicate its investment thesis and to build an important momentum for the company’s investment story.